Analyst firms · Argus Research · RTX
Argus Research RTX price target and rating history
RTX Corporation (RTX) · Industrials
Argus Research rates RTX Corporation (RTX) Buy with a $100 price target, as of its latest action on Feb 11, 2025. It has published 3 rating actions on RTX since July 2021, including 2 upgrades and 1 downgrade. Across 7 firms with a RTX price target in the last 12 months, the median target is $210.
- Current rating
- Buy
- Price target
- $100
- Median target, all firms
- $210
- Actions on RTX
- 3
Every Argus Research rating on RTX
- Feb 11, 2025
- Jul 31, 2023
- Jul 29, 2021
How other firms rate RTX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Deutsche Bank | Hold | $208 | Oct 13, 2026 |
| Barclays | Overweight | $223 | Oct 9, 2026 |
| Jefferies | Buy | $220 | Jun 4, 2026 |
| Erste Group | Hold | Apr 27, 2026 | |
| Melius | Buy | Apr 3, 2026 | |
| Wells Fargo | Equal Weight | $200 | Apr 1, 2026 |
| UBS | Neutral | $199 | Jan 5, 2026 |
| Citigroup | Buy | $211 | Dec 12, 2025 |
| BNP Paribas Exane | Outperform | $210 | Nov 18, 2025 |
Questions about Argus Research and RTX
- What is Argus Research's price target for RTX?
- Argus Research's latest stated price target for RTX Corporation (RTX) is $100, from its action on Jul 29, 2021.
- What is Argus Research's rating on RTX?
- Argus Research rates RTX Buy, a bullish rating, as of Feb 11, 2025.
- When did Argus Research last change its view on RTX?
- On Feb 11, 2025, Argus Research upgrades to Buy from Hold.
- How does Argus Research's RTX target compare with other analysts?
- Across 7 firms with a RTX price target in the last 12 months, the median target is $210.
More RTX rating histories
- Deutsche Bank5
- Barclays3
- Wells Fargo3
- UBS3
- Citigroup3
- Morgan Stanley4
- RBC Capital Markets3
- BofA Securities4
- Wolfe Research3
All Argus Research ratingsRTX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.